Država: Malta
Jezik: angleščina
Source: Medicines Authority
ATENOLOL
Wockhardt UK Limited Ash Road North, Wrexham, LL13 9UF, United Kingdom
C07AB03
ATENOLOL 25 mg
TABLET
ATENOLOL 25 mg
POM
BETA BLOCKING AGENTS
Withdrawn
2006-08-23
Page 1 of 14 PACKAGE LEAFLET: INFORMATION FOR THE USER ATENOLOL 25MG TABLETS ATENOLOL 50MG FILM-COATED TABLETS ATENOLOL 100MG FILM-COATED TABLETS Atenolol (Referred to as Atenolol Tablets in this leaflet) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE_ _BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Atenolol Tablets are and what they are used for 2. What you need to know before you take Atenolol Tablets 3. How to take Atenolol Tablets 4. Possible side effects 5. How to store Atenolol Tablets 6. Contents of the pack and other information 1. WHAT ATENOLOL TABLETS ARE AND WHAT THEY ARE USED FOR Atenolol Tablets contain a medicine called atenolol. This belongs to a group of medicines called beta-blockers. Atenolol Tablets are used to: Treat high blood pressure (hypertension). Treat uneven heart beats (arrhythmias). Help prevent chest pain (angina). Protect the heart in the early treatment after a heart attack (myocardial infarction). They work by making your heart beat more slowly and with less force. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ATENOLOL TABLETS DO NOT TAKE ATENOLOL TABLETS: If you are allergic to atenolol or any of the other ingredients of this medicine (listed in section 6) If you have ever had any of the following heart problems: heart failure which is not under control (this usually makes you breathless and causes your ankles to swell) second- or third-degree heart block (a condition which may be treated by a pacemaker) very slow or very uneven heart beats, very low blood pressure or Preberite celoten dokument
Page 1 of 10 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Atenolol 25mg Tablets or Totamol 25mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Atenolol 25mg For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Atenolol is indicated for: Management of hypertension. Management of angina pectoris. Management of cardiac arrhythmias. Myocardial infarction. Early intervention in the acute phase. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The dose must always be adjusted to individual requirements of the patients, with the lowest possible starting dosage. The following are guidelines: _ _ _ADULTS:_ HYPERTENSION 100 mg daily. Most patients respond to 100 mg daily given orally as a single dose. Some patients, however, will respond to 50 mg given as a single daily dose. The effect will be fully established after one to two weeks. A further reduction in blood pressure may be achieved by combining atenolol with other antihypertensive agents. For example co- administration of atenolol with a diuretic, as in Tenoretic, provides a highly effective and convenient antihypertensive therapy. ANGINA Most patients with angina pectoris will respond to 100 mg given orally once daily or 50 mg given twice daily. It is unlikely that additional benefit will be gained by increasing the dose. CARDIAC ARRHYTHMIAS Having controlled the arrhythmias with intravenous atenolol, a suitable oral maintenance dosage is 50–100 mg daily, given as a single dose. MYOCARDIAL INFARCTION For patients suitable for treatment with intravenous beta-blockade and presenting within 12 hours of the onset of chest pain, following treatment with intravenous atenolol, 50 mg oral atenolol may be given about 15 minutes later, provided no untoward effects have occurred from the intravenous dose. This should be followed by a further 50 mg orally 12 hours after the intravenous dose, and then 12 hours later by 100 mg orally, once daily. If bradycar Preberite celoten dokument